Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Sativex approved in Wales to treat MS symptoms on NHS

29th August 2014

The cannabinoid Sativex (delta-9-tetrahydrocannabinol/cannabidiol) can now be prescribed on the NHS in Wales to treat symptoms of multiple sclerosis.

The decision taken by the All Wales Medicines Strategy Group was given ministerial approval and supersedes the recommendation made earlier this year, in draft guidance by the National Institute for Health and Care Excellence (NICE), that the drug should not be made available in England and Wales because it is not cost effective.

click here to view